title: The use of 90yttrium-ibritumomab tiuxetan in patients on dialysis: what do we know regarding its pharmacokinetics?
authors.affiliation: Division of Nephrology and Hypertension.
authors.forename: Nelson
authors.initials: N
authors.lastname: Leung
authors.forename: Thomas E
authors.initials: TE
authors.lastname: Witzig
mesh_terms: D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D006801:Humans; D008224:Lymphoma, Follicular / Q000473:pathology* / Q000532:radiotherapy*; D008297:Male; D016499:Radioimmunotherapy
chemical_list: D000911:Antibodies, Monoclonal; C422802:ibritumomab tiuxetan